Home » Stocks » ENDP

Endo International PLC (ENDP)

Stock Price: $6.93 USD 0.12 (1.76%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
After-hours: $6.86 -0.07 (-1.01%) Jan 22, 7:35 PM
Market Cap 1.60B
Revenue (ttm) 2.91B
Net Income (ttm) -154.04M
Shares Out 230.04M
EPS (ttm) -0.68
PE Ratio n/a
Forward PE 2.86
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $6.93
Previous Close $6.81
Change ($) 0.12
Change (%) 1.76%
Day's Open 6.67
Day's Range 6.65 - 6.96
Day's Volume 4,052,120
52-Week Range 2.28 - 7.97

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 1 week ago

Does Endo International (ENDP) have what it takes to be a top stock pick for momentum investors? Let's find out.

PRNewsWire - 1 month ago

DUBLIN, Dec. 18, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference on Tuesday, January...

Zacks Investment Research - 1 month ago

Endo (ENDP) reported earnings 30 days ago. What's next for the stock?

PRNewsWire - 2 months ago

DUBLIN, Nov. 18, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that the Company will participate in two investor conferences. Members of management will participat...

Zacks Investment Research - 2 months ago

Is Endo International (ENDP) a great pick from the value investor's perspective right now? Read on to know more.

Seeking Alpha - 2 months ago

Endo International plc (ENDP) CEO Blaise Coleman on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Endo's (ENDP) earnings and sales beat estimates in the third quarter. The company raises its annual outlook.

Zacks Investment Research - 2 months ago

Endo (ENDP) delivered earnings and revenue surprises of 271.43% and 13.72%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

PRNewsWire - 2 months ago

DUBLIN, Nov. 5, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2020. "Our third-quarter 2020 results refl...

PRNewsWire - 2 months ago

- Initiatives to Enable Company to Reinvest in Key Areas of Growth - DUBLIN, Nov. 5, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the initiation of several strate...

PRNewsWire - 2 months ago

GOTHENBURG, Sweden, Nov. 2, 2020 /PRNewswire/ -- Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) is pleased to announce today a definitive license agree...

PRNewsWire - 2 months ago

GOTHENBURG, Sweden, Nov. 2, 2020 /PRNewswire/ -- Isofol Medical AB (publ) ("Isofol"), (Nasdaq First North Premier Growth Market: ISOFOL) has today announced a definitive licensing agreement wi...

PRNewsWire - 2 months ago

DUBLIN, Nov. 2, 2020 /PRNewswire/ -- Endo International plc (Nasdaq: ENDP) ("Endo") today announced that Endo's wholly-owned indirect subsidiary, Beta Acquisition Corp. ("Merger Sub"), has com...

Zacks Investment Research - 2 months ago

Endo (ENDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 3 months ago

Endo (ENDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - October 21, 2020) - [DATELINE]Rowley Law PLLC is investigating potential securities law violations by BioSpecifics Technologies Corp. (NASDAQ: BSTC) and i...

Other stocks mentioned: BSTC
Zacks Investment Research - 3 months ago

Endo (ENDP) gains from the acquisition of commercial-stage biopharmaceutical company, BioSpecifics Technologies Corp.

The Motley Fool - 3 months ago

Investors are fired up about Endo's planned acquisition of BioSpecifics.

Other stocks mentioned: BSTC
24/7 Wall Street - 3 months ago

News that Endo International PLC (NASDAQ: ENDP) would acquire BioSpecifics Technologies Corp.

Other stocks mentioned: BSTC
PRNewsWire - 3 months ago

WILMINGTON, Del., Oct. 19, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC) announced today that it has entered into a definitive merger agreement under which Endo Internati...

Other stocks mentioned: BSTC
PRNewsWire - 3 months ago

-- Endo to acquire BioSpecifics in an accretive all-cash transaction -- DUBLIN, Oct. 19, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced it has agreed to acquire all...

Other stocks mentioned: BSTC
PRNewsWire - 3 months ago

DUBLIN, Oct. 9, 2020 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today announced that data relevant to the use of Endo Aesthetics' Qwo™ (collagenase clostridium histolyticum-aaes) for...

PRNewsWire - 3 months ago

DUBLIN, Oct. 7, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its third–quarter 2020 financial results on November 5, 2020 after the market closes and members of its...

Zacks Investment Research - 3 months ago

Investors need to pay close attention to Endo (ENDP) stock based on the movements in the options market lately.

PRNewsWire - 3 months ago

DUBLIN, Oct. 6, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the release of its first Environmental, Social and Governance (ESG) report, titled 2019 Corporate Res...

PRNewsWire - 3 months ago

DUBLIN, Oct. 1, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiary, Par Pharmaceutical, Inc. (Par), has begun shipping sapropterin dihydrochloride t...

Zacks Investment Research - 3 months ago

Endo (ENDP) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Invezz - 3 months ago

Novavax Inc. (NASDAQ: NVAX) said that Endo International (NASDAQ: ENDP) will be in charge of manufacturing its COVID-19 vaccine after the two companies inked a non-exclusive agreement on Frida...

Other stocks mentioned: NVAX
The Motley Fool - 3 months ago

The two companies signed a manufacturing agreement.

Other stocks mentioned: NVAX
PRNewsWire - 3 months ago

DUBLIN, Sept. 25, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiary, Par Sterile Products, LLC (Par Sterile) has entered into a non-exclusive agree...

PRNewsWire - 4 months ago

DUBLIN, Sept. 24, 2020 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today announced that it will present data relevant to the use of Qwo™ (collagenase clostridium histolyticum-aaes) fo...

PRNewsWire - 4 months ago

DUBLIN, Sept. 8, 2020 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that it will participate in the Citi 15th Annual BioPharma Virtual Conference being held September 8...

Zacks Investment Research - 4 months ago

Endo (ENDP) reported earnings 30 days ago. What's next for the stock?

PRNewsWire - 5 months ago

DUBLIN, Aug. 21, 2020 /PRNewswire/ -- Endo International plc (the "Company") (NASDAQ: ENDP) announced today the expiration and final tender results of the previously announced cash tender offe...

Newsfile Corp - 5 months ago

New York, New York--(Newsfile Corp. - August 18, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...

Newsfile Corp - 5 months ago

Los Angeles, California--(Newsfile Corp. - August 18, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo In...

Newsfile Corp - 5 months ago

New York, New York--(Newsfile Corp. - August 17, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Endo International plc ("Endo" or the "Company") (N...

Business Wire - 5 months ago

LOS ANGELES--(BUSINESS WIRE)---- $ENDP #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming August 18, 2020 deadline to file a lead plaintiff motion in the class ac...

Newsfile Corp - 5 months ago

New York, New York--(Newsfile Corp. - August 17, 2020) - Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Endo International plc ("Endo"...

Newsfile Corp - 5 months ago

Los Angeles, California--(Newsfile Corp. - August 17, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo In...

Newsfile Corp - 5 months ago

Los Angeles, California--(Newsfile Corp. - August 16, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo In...

Newsfile Corp - 5 months ago

New York, New York--(Newsfile Corp. - August 14, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Endo International Plc (NASDAQ: ...

Newsfile Corp - 5 months ago

Los Angeles, California--(Newsfile Corp. - August 13, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo In...

Newsfile Corp - 5 months ago

Los Angeles, California--(Newsfile Corp. - August 12, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Endo I...

Newsfile Corp - 5 months ago

New York, New York--(Newsfile Corp. - August 10, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Endo International plc ("Endo" or the "Company") (N...

Seeking Alpha - 5 months ago

Endo International plc's (ENDP) CEO Blaise Coleman on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Endo's (ENDP) earnings and sales beat estimates in the second quarter as COVID-19-related restrictions ease out.

Zacks Investment Research - 5 months ago

Endo (ENDP) delivered earnings and revenue surprises of 85.71% and 7.77%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

PRNewsWire - 5 months ago

— Revenues decreased 2% to $688 million compared to prior year — — On July 6, 2020, U.S. FDA approved Qwo™ (collagenase clostridium histolyticum-aaes), the first injectable treatment for cellu...

PRNewsWire - 5 months ago

LOS ANGELES, Aug. 5, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming August 18, 2020 deadline to file a lead plaintiff motion in the class action fil...

About ENDP

Endo International plc manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; TESTOPEL for TRT in conditions associated with a deficiency or absence of endogenous testosterone; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-mode... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Sep 25, 1996
CEO
Blaise Coleman
Employees
3,172
Stock Exchange
NASDAQ
Ticker Symbol
ENDP
Full Company Profile

Financial Performance

In 2019, ENDP's revenue was $2.91 billion, a decrease of -1.11% compared to the previous year's $2.95 billion. Losses were -$422.64 million, -59.03% less than in 2018.

Financial Statements

Analyst Forecasts

According to 15 analysts, the average rating for ENDP stock is "Hold." The 12-month stock price forecast is 6.45, which is a decrease of -6.93% from the latest price.

Price Target
$6.45
(-6.93% downside)
Analyst Consensus: Hold